研究人员从GEO公共数据库中选择了具有动脉粥样硬化保护效果的干预（他汀类药物或层流剪切应力）测序数据集，以及动脉粥样硬化患者斑块的基因表达数据集，发现胰岛素样生长因子结合蛋白6（IGFBP6）可能是一种潜在的血管稳态相关分子。已有研究表明，IGFBP ...

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

Medically reviewed by Anisha Shah, MD "Vascular disease" is a term given to conditions that affect the blood vessels that ...

Novel drugs for atherosclerosis have taken a hard hit in the past year, making it unlikely that any will make it to market this decade. But lessons learned from these failures might help the ...

The factors underlying accelerated atherosclerosis in diabetes extend beyond dyslipidemia, hypertension and obesity. Even after correction of these typical risk factors, patients with diabetes ...

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Atherosclerosis happens when a fatty substance called plaque builds up inside your arteries. There are typically few noticeable ...

This country research report on Vietnam Atherosclerosis Drugs Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

Type 2 diabetes worsens atherosclerosis; new research identifies molecular targets for improved cardiovascular treatment.

While millions of Americans have some form of atherosclerosis, or clogged arteries, there are foods that can prevent it ...

Heart disease is one of the leading causes of death in Western countries. A common form of this condition is atherosclerosis, ...